Don’t Discount These Cannabis Penny Stocks

A decade from now, investors may very well look back and proclaim the cannabis industry to be the greatest growth opportunity of our generation. We know the demand is there given the tens of billions of dollars that exchanges hands in illicit channels each year. It's simply a matter of ongoing legalizations and ramp-up efforts to move those black-market pot sales into legal channels. If this happens, $75 billion in annual sales by 2030 is easily achievable, according to one Wall Street firm.

But what you may not realize is that while many of the major legal players have billion-dollar market caps, not all of them fit the mold of what you'd think a major cannabis company would look like. Right now, there are three marijuana penny stocks that are expected to be very important players in the Canadian pot industry.

Read the full article at The Motley Fool.

Don’t Stop Here

More To Explore

ZTS: 3 Key Takeaways for Savvy Investors!

Disclaimer: This report is for informational and educational purposes only and does not constitute professional financial or investment advice. Furthermore, mentions of specific veterinary therapeutics

PAHC Q1 Earnings: Key Metrics You Can’t Ignore!

The synthesis of this valuation gap requires understanding market dynamics. Investors assign premium multiples to companion animal health businesses (like Idexx Laboratories or the companion

FLYW Q3 Call Reveals Game-Changing Insights!

Adyen (ADYEN.AS): A dominant European horizontal player trading at significantly higher growth multiples—commanding a ~5.0x EV/Revenue multiple and ~21.6x forward EV/EBITDA [cite: 1, 2]—largely due